Bio-link Australia Pty. Ltd.


Please find below a list of selected recent news and press releases from Bio-Link, our clients and the industry. Please select a specific news list for each source from the buttons on the left hand side.

24th May 2012 – Bio-Link Engaged by Bionomics Limited

Bio-Link has been engaged by Bionomics (ASX:BNO) to provide business development services for certain drug development programs in its pipeline, including the Alpha 7 Program for cognitive impairment.

19th April 2012 – Akimba Mouse Model Deal Announcement

Bio-Link has facilitated a commercial arrangement between the Lions Eye Institute (LEI), Perth and Regeneron Pharmaceuticals, Inc (NASDAQ:REGN) around the Akimba model of diabetic retinopathy developed by Prof. Elizabeth Rackoczy and her colleagues at LEI.

31st October, 2011 – Partnering Event – BioEurope 2011

Bio-Link participated in the BioEurope partnering conference (Dusseldorf, Germany), 31st October – 2nd November, presenting its portfolio of opportunities in human and veterinary therapeutics to potential partners and licensees.

12th October, 2011 – Deal Announcement – Clathrin Inhibitors

Bio-Link has facilitated a global licence, supply and distribution agreement for the first rationally designed clathrin inhibitors. The deal between Freie Universitaet Berlin,  Children’s Medical Research Institute,  University of Newcastle and Ascent Scientific (United Kingdom) covers inclusion of these compounds in Ascent’s catalogue for research uses ..more

25th July 2011 – Deal Announcement

Bio-Link has facilitated a commercial partnership between Capital Biosciences Inc. (USA) and the Children’s Medical Research Institute for a new testing service based on the analysis of telomere maintenance. Click here for the full press release.